(ACHN:Consolidated Issue Listed on NASDAQ Global Select )
Robert L. Van Nostrand BS
Director, Chairman of Audit Committee and Member of Compensation Committee, Achillion Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 40 board members in 5 different organizations across 6 different industries.|
See Board Relationships
Mr. Robert L. Van Nostrand, also known as Bob, BS served as Chief Financial Officer and Executive Vice President of Aureon Laboratories, Inc. since January 2010. Mr. Van Nostrand has responsibility for all financial aspects of the Aureon Laboratories's activities. He served as Executive Vice President and Chief Financial Officer of Aureon Biosciences, Inc., from January 2010 to July 2010. He served as the Chief Financial Officer and an Executive Vice President of Applied ...
300 George StreetPhone: 203-624-7000
New Haven, Connecticut 06511
Board Members Memberships*
Independent Director and Member of Audit Committee
Chairman, Chairman of Audit Committee and Member of Compensation Committee
Director, Chairman of Audit Committee and Member of Compensation Committee
Director and Chairman of Audit Committee
Lead Independent Director, Member of Audit Committee, Member of Nominating & Governance Committee and Member of Compensation Committee
Long Island University
University of Pennsylvania - The Wharton School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Mamoru Kadokura||President and Representative Director|
|Jun Suzuki||Chief Executive Officer, President, Member of Advisory Board and Representative Director |
|Tjerk de Ruiter||Chief Executive Officer and Member of Management Board|
|Hideo Ichikawa||Chief Executive Officer, President, Representative Director and Chairman of CSR Committee|
Showa Denko K.K.
|Paul R. Mines||Chief Executive Officer and Executive Director|
Biome Technologies plc
|155.0K GBP||Compensation as of Fiscal Year --.|